Although the diagnosis of PCa based on PSA levels alone is not reliable, combining PSA measurements with other approaches might strengthen the diagnostic value of PSA measurements and identifying its clinical risk, and it is based on this concept that the current study has been performed. The gene discussed is KLK3; the disease is posterior cortical atrophy.